An anti-inflammatory drug has significantly lowered the risk of recurrent heart attacks, strokes and cardiovascular death, all without reducing cholesterol, according to research recently published in the New England Journal of Medicine and shared at a meeting of the European Society of Cardiology.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.